The Department of Health want to measure achievements

There’s a paper on measuring the fund’s nine performance indicators, which are largely about inputs and stakeholders.

But two cover outcomes, “healthcare change” and “commercialisation pathways.”

Indicators for these include, “result in new treatments,” “withdrawal of ineffective treatments” plus clinical trials, start-ups and patents – which surely are the ones that really matter.

These, as well as all the bumf officials want, will be recorded from reports from funded researchers, – and yes, there will be a survey. But fear not, “the Department will take care to minimise burden on grantees, by considering the content, length, response format and timing.”

Course it will.